This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $149,949
Peptide therapeutics for preventing retinal ganglion cell apoptosis
CIHR · 2014 · Nominated PI
- $130,000
Molecular Interactions that modulate PI3 Kinase and MAP Kinase pathways during apoptosis
NSERC · 2012 · Principal investigator
- $554,525
Focal Adhesion Kinase: A Pivotal Factor in the degeneration and regeneration of adult CNS neurons
CIHR · 2011 · Nominated PI
Peptide therapeutics for preventing retinal ganglion cell apoptosis
Principal investigators: Koeberle, Paulo D
Keywords: Apoptosis; Glaucoma; Peptide; Retinal Ganglion Cell; Visual Disease
Molecular Interactions that modulate PI3 Kinase and MAP Kinase pathways during apoptosis
Principal investigators: Koeberle, Paulo
Focal Adhesion Kinase: A Pivotal Factor in the degeneration and regeneration of adult CNS neurons
Principal investigators: Koeberle, Paulo D
Keywords: Apoptosis; Axon Regeneration; Axotomy; Caspase; Glaucoma; Kinase; Optic Nerve Crush; Optic Nerve Transection; Retinal Ganglion Cell; Vision Loss
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.